| Literature DB >> 33936280 |
Weihua Hu1, Ke Yang1, Li Zhang1, Xu Lu2.
Abstract
Audio-visual (AV) or music distraction may be used to reduce pain during several healthcare procedures. The present manuscript is a systematic review and meta-analysis to assess the effectiveness of media distraction in reducing pain and anxiety in extracorporeal shock wave lithotripsy (ESWL) patients. The PubMed, Embase, Scopus, BioMed Central, Ovoid and CENTRAL (Cochrane Central Register of Controlled Trials) databases were screened for studies assessing the role of media distraction (music/AV media) in reducing pain and anxiety of ESWL patients. Data were summarized using the mean difference (MD) with 95% confidence intervals (CI). A total of 11 randomized controlled trials were included. Pooled analysis indicated a statistically significant difference in pain outcomes with media distraction [mean difference (MD): -1.18; 95% CI: -2.35, -0.01; I2=96.8%)]. Subgroup analysis indicated that both AV media (MD: -2.94; 95% CI: -4.70, -1.17; I2=79.2%) and music (MD: -0.86; 95% CI: -1.37, -0.35; I2=62.5%), led to significant reduction in pain outcomes. Pooled analysis indicated a statistically significant reduction of anxiety scores with the use of media distraction (MD: -3.91; 95% CI: -6.44, -1.38; I2=77.7%). To conclude, the present review suggests that media distraction in the form of AV media or music may be beneficial in reducing the pain and anxiety of patients undergoing ESWL. Evidence is, however, weak considering the small effect size, confidence intervals being close to zero, and instability of the results on sensitivity analysis. In clinical practice, media distraction may be used during ESWL as a nursing intervention, but a clinically important reduction of pain and anxiety may not be expected. Copyright: © Hu et al.Entities:
Keywords: analgesia; audiovisual; complementary therapy; distraction; music; renal stones; urology
Year: 2021 PMID: 33936280 PMCID: PMC8082642 DOI: 10.3892/etm.2021.10055
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
Figure 1Study flow-chart.
Characteristics of included studies.
| Sample size | Mean age | Male sex (%) | Number of shock waves | ESWL power settings | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Author/Year | Inclusion criteria | Exclusion criteria | Study | Control | Study | Control | Study | Control | Media distraction | Study | Control | Study | Control | Analgesia during procedure |
| Cepeda | Age: 15-65 years First ESWL | Serum creatinine >1.5 mg/dl History of opioid use | 97 | 96 | 40.7 | 41 | 49.4 | 48.9 | Patient selected classical, Caribbean, soft rock, and jazz music via headphones started 10 mins before procedure and continued up to 10 mins post- procedure | NR | NR | All patients reached 17 V | Morphine 10 mg SC with ketor olac 30 mg IV + alfentanil PCA (0.25 mg dose with 1 min lockout interval) | |
| Koch | NR | NR | 21 | 22 | 54 | 53 | 80 | 44 | Any music pf patients choice via headphone during procedure | NR | NR | NR | NR | Midazolam and Alfentanil 10 µg/kg PCA |
| Yilmaz | Age: 19-68 years | NR | 48 | 50 | 40.8 | 39.3 | 60.4 | 64 | Relaxing, slow rhythm sedative music via headphones during procedure | 3043± 110.42 | 3016± 64.22 | 21.96± 0.54 kV | 21.03± 0.48 kV | 15 g emla cream over flank, 25 mg fentanyl IV given to patients reporting pain. Midazolam 2 mg in control group only |
| Marsdin | Elective outpatient ESWL patients | Ureteric stents Emergency patients | 61 | 57 | 51.7 | 53.5 | 54 | 56 | 32-inch television with 30 different DVDs of 30-min programs provided with wireless headphones | 3948± NR | 3764± NR | NR | NR | Pethidine 100 mg IM and diclofenac 75 mg IM |
| Akbas | Age: >18 y No preoperative pain No analgesic use before the procedure No ureteral stent inserted Radio-opaque stone | Not completed procedure Development of complications Refusing to listen to music Not completing the second session | 200 | 200 | - | - | - | - | Turkish folk, classical, popular music during procedure | 2724± 492 | 2710± 551 | 17.71± 2.59 J | 17.04± 2.07 J | None |
| Karalar | Radio- opaque renal stone | Prior ESWL Ureteric stents Renal colic | S1: 28 S2: 29 | 32 | S1: 47.8 S2: 47.7 | 48.2 | S1: 61 S2: 62 | 59 | S1: Turkish classical music by noise cancellation headphones during procedure S2: Turkish classical music via non noise cancellation headphones during procedure | 2913± 444 | 2828± 272 | 20.1± 1.1 kV | 19.9± 1.3 kV | Diclofenac 75 mg IM |
| Cakmak | Age: >18 y Radio-opaque renal stone Located in upper/middle calices, renal pelvis: <20 mm in diameter Proximal ureter: <10 mm in diameter | Prior ESWL Ureteric stents Hearing disorders Uncontrolled hypertension History of psychiatric disease and antidepressant drug use | 95 | 105 | NR | NR | NR | NR | Turkish folk, classical, popular, relaxing or slow rhythm music via headphones during procedure | 2764.5± 699.1 | 2777.9± 724.9 | 17.4± 5.3 kV | 17.5± 5.5 kV | NR |
| Jurado | Age: 18-80 y | Prior ESWL Hearing loss Analgesia prior to procedure Regularly taking painkillers | 42 | 53 | 52.6 | 52 | 54.8 | 69.8 | Patient selected classical, chill out, pop, jazz music via by noise cancellation headphones during procedure | NR[ | NR | NR[ | NR | Pethidine 20 mg IV and paracetamol 1 g IV. 10 cc (max 50 cc) of pethidine given to patients reporting pain. |
| Gezginci | Age: >18 y First ESWL BMI: <30 kg/m2 No contradiction for ESWL | Analgesic before procedure Renal colic before procedure Ureteric stents | 40 | 40 | NR[ | NR | 33.3 | 35.2 | Patient selected Turkish (folk, art, arabesque, pop) music, foreign pop music, rock and classical music via headphones during procedure | Targeted 3,000 per session | NR | NR | None | |
| El-Khoury | Adult patients | NR | AV media: 33 Music: 30 | 31 | AV media: 52.4 Music: 51.5 | 52.6 | AV media: 70 Music: 90 | 71 | AV media: music videos using Apple iPad Music: Any music/local radio Both delivered by noise cancellation headphones during procedure | AV media: 3205.9± 545.3 Music: 3175.1± 434.1 | 3150.4± 424.5 | AV media: 74.3± 10 kV Music: 74.3± 9.1 kV | 70.4±16 kV | NSAID suppository offered to all patients. Breakthrough pain treated by Fentanyl IM |
| Çift | Age: >18 years Radiopaque stone 10-20 mm in diameter localized in the renal pelvis or ureteropelvic junction Absence of renal colic before the procedure | Previous ESWL history Ureteral stent Hearing deficit, Uncontrolled hypertension Antidepressant drug usage | S1: 30 S2: 30 S3: 30 | C1: 30 C2: 30 | S1: 37.7 S2: 36.3 S3: 36.4 | C1: 38.4 C2: 39.2 | S1: 83.3 S2: 70 S3: 73.3 | C1: 53.3 C2: 56.7 | S1: Turkish art music S2: Western classical music S3: Patient selected any type of music. All delivered via headphones during procedure C1: No headphones, no music C2: Headphones on, no music | S1: 2851.5 (2685.7-3000) S2: 2842.5 (2437.2-2958.7) S3: 2800 (2500-2925) | C1: 2700 (2500-2900) C2: 2725 (2500-2900) | S1: 92 (82-101.25) S2: 90 (64.25-103.5) S3: 94 (79.75-96.25) | C1: 80 (74.75-92.5) C2: 85 (65.0-93.25) | None |
Data presented as the mean ± SD.
aNo difference between the two groups for number of shock waves and energy, but data not reported as the mean ± SD. AV, audiovisual; ESWL, extracorporeal shock wave lithotripsy; PCA, patient controlled analgesia; SC, subcutaneous; IM, intramuscular; IV, intravenous; BMI, body mass index; S1, study group 1; S2, study group 2; S3, study group 3; C1, control group 1; C2, control group 2; NR, not reported; V, volts; kV, kilovolts; J, Joules.
Risk of bias in included studies.
| Study | Random sequence generation | Allocation concealment | Blinding of participants and personnel | Blinding of outcome assessment | Incomplete outcome data | Selective reporting | Other bias |
|---|---|---|---|---|---|---|---|
| Cepeda | Unclear risk | Unclear risk | High risk | High risk | Low risk | Unclear risk | Unclear risk |
| Koch | Unclear risk | Unclear risk | High risk | High risk | Low risk | Unclear risk | Unclear risk |
| Yilmaz | Unclear risk | Unclear risk | High risk | High risk | Low risk | Unclear risk | High risk |
| Marsdin | Unclear risk | Unclear risk | High risk | High risk | Low risk | Unclear risk | Unclear risk |
| Akbas | Unclear risk | Unclear risk | High risk | High risk | Low risk | Unclear risk | Low risk |
| Karalar | High risk | Unclear risk | High risk | High risk | Low risk | Unclear risk | Unclear risk |
| Cakmak | Unclear risk | Unclear risk | High risk | High risk | Low risk | Unclear risk | Low risk |
| Jurado | Low risk | Unclear risk | High risk | Low risk | Low risk | Unclear risk | Unclear risk |
| Gezginci | Low risk | Unclear risk | High risk | High risk | Low risk | Low risk | Low risk |
| El-Khoury | Low risk | Unclear risk | High risk | High risk | Low risk | Unclear risk | Unclear risk |
| Çift | Low risk | Low risk | High risk | Low risk | Low risk | Unclear risk | Low risk |
Figure 2Forest plot of studies comparing media distraction vs. control for the outcome pain with sub-group analysis based on the type of media distraction (audiovisual or music). *Indicates different sub-group from the same study.
Figure 3Sensitivity analysis of pain outcome presenting the resultant effect size after exclusion of one study at a time. Black squares in front of each study indicate the effect size and horizontal lines indicate the 95% confidence intervals, after exclusion of that study from the analysis. *Indicates different sub-group from the same study.
Figure 4Forest plot of studies comparing media distraction vs. control for the outcome pain with sub-group analysis based on the use of noise-cancelling headphones (NCH). *Indicates different sub-group from the same study.
Figure 5Forest plot of studies comparing media distraction vs. control for the outcome anxiety.
Figure 6Sensitivity analysis of anxiety outcome presenting the resultant effect size after exclusion of one study at a time.*Indicates different sub-group from the same study.